Playing by the Rules: Demystifying the Landscape of Cosmetic and Drug Regulatory Classifications in Dermatology
If you have ever wondered how an ingredient progresses from the laboratory bench to the beauty aisle, or why some products make bold efficacy claims while others remain vague, the field of regulatory affairs is the answer. Acting as the bridge between product innovation and the FDA, regulatory professionals ensure that skin care products of all kinds are compliant with U.S. law. In this session at …
If you have ever wondered how an ingredient progresses from the laboratory bench to the beauty aisle, or why some products make bold efficacy claims while others remain vague, the field of regulatory affairs is the answer. Acting as the bridge between product innovation and the FDA, regulatory professionals ensure that skin care products of all kinds are compliant with U.S. law. In this session at … 
The use of artificial intelligence (AI) programs such as ChatGPT is a source of controversy in academia, including in the college admissions process. Are applicants for dermatology residency programs using AI to write or enhance their personal statements, and if so, to what extent? A study published in the May Journal of Drugs in Dermatology found a significant increase in AI usage in dermatology … 
What is the first-line therapy for the mild-moderate disease depicted in the image?
A. Narrow-band UVB
B. Biologic agents
C. Acitretin
D. Topical glucocorticoids
E. Methotrexate
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers. … 
Welcome to our newest blog series, From the JDD Podcast Vault, where we spotlight standout episodes from the JDD Dermatology Podcast, hosted by the always-engaging Dr. Adam Friedman. Each post will revisit compelling conversations that continue to educate, inspire, and provoke thought in dermatologic practice.
In this featured episode, “Wondering About Words: Evidence-Based Framing for Improvin … 
The management of acne vulgaris has long included a balance between prescription and over-the-counter (OTC) therapies. OTC therapies are typically first-line treatment for most patients, and may be all that is needed to control less severe acne. At the recent Lab to Label Conference, Dr. Hilary Baldwin, a board-certified dermatologist and medical director of the Acne Treatment & Research Cente …